Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Bott

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Antiviral Research|February 19, 2025
Recombinant Pichinde reporter virus as a safe and suitable surrogate for high-throughput antiviral screening against highly pathogenic arenavirusesCarolina Q Sacramento, Ryan Bott, Qinfeng Huang, et al.
Journal of Medicinal Chemistry|August 22, 2024
N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry InhibitorsDestiny Durante, Ryan Bott, Laura Cooper, et al.
Journal of Medicinal Chemistry|October 19, 2022
Synthesis, Optimization, and Structure-Activity Relationships of Imidazo[1,2-<i>a</i>]pyrimidines as Inhibitors of Group 2 Influenza A VirusesSaad Alqarni, Laura Cooper, Jazmin Galvan Achi, et al.
European Journal of Medicinal Chemistry|May 3, 2025
Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A virusesMalaika D Argade, Varada Anirudhan, Sean P Bradley, et al.
European Journal of Medicinal Chemistry|May 21, 2025
Corrigendum to "Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses" [Europ. J. Med. Chem. 2925 (2025) 117679]Malaika D Argade, Varada Anirudhan, Sean P Bradley, et al.
Journal of Medicinal Chemistry|December 16, 2024
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg VirusesMalaika D Argade, Jazmin Galván Achi, Ryan Bott, et al.
Journal of Medicinal Chemistry|January 6, 2026
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of HenipavirusesIrina N Gaisina, Malaika D Argade, Ryan Bott, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Antiviral Research|February 19, 2025
Recombinant Pichinde reporter virus as a safe and suitable surrogate for high-throughput antiviral screening against highly pathogenic arenavirusesCarolina Q Sacramento, Ryan Bott, Qinfeng Huang, et al.
Journal of Medicinal Chemistry|August 22, 2024
N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry InhibitorsDestiny Durante, Ryan Bott, Laura Cooper, et al.
Journal of Medicinal Chemistry|October 19, 2022
Synthesis, Optimization, and Structure-Activity Relationships of Imidazo[1,2-<i>a</i>]pyrimidines as Inhibitors of Group 2 Influenza A VirusesSaad Alqarni, Laura Cooper, Jazmin Galvan Achi, et al.
European Journal of Medicinal Chemistry|May 3, 2025
Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A virusesMalaika D Argade, Varada Anirudhan, Sean P Bradley, et al.
European Journal of Medicinal Chemistry|May 21, 2025
Corrigendum to "Refinement of imidazo[2,1-a]pyrimidines in pursuit of potential drug candidates against group 2 influenza A viruses" [Europ. J. Med. Chem. 2925 (2025) 117679]Malaika D Argade, Varada Anirudhan, Sean P Bradley, et al.
Journal of Medicinal Chemistry|December 16, 2024
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg VirusesMalaika D Argade, Jazmin Galván Achi, Ryan Bott, et al.
Journal of Medicinal Chemistry|January 6, 2026
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of HenipavirusesIrina N Gaisina, Malaika D Argade, Ryan Bott, et al.
Pageof 1